Under the licensing agreement, Pfizer will not receive royalties from the manufacturers, making the treatment cheaper
US pharmaceutical giant Pfizer has announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least-wealthy countries.
Pfizer will allow generic manufacturers to supply its promising Paxlovid pill to 95 low-and middle-income nations covering about 53% of the world’s population, the company said in a statement on Tuesday.
Continue reading...source https://www.theguardian.com/business/2021/nov/17/pfizer-strikes-deal-to-allow-generic-versions-of-its-covid-pill-for-worlds-poor
No comments:
Post a Comment